Bilgic, A.; Kodjikian, L.; Vasavada, S.; Jha, S.; Srivastava, S.; Sudhalkar, A.; Mathis, T.
Brolucizumab for Choroidal Neovascular Membrane with Pigment Epithelial Tear and Subretinal Fluid. J. Clin. Med. 2021, 10, 2425.
https://doi.org/10.3390/jcm10112425
AMA Style
Bilgic A, Kodjikian L, Vasavada S, Jha S, Srivastava S, Sudhalkar A, Mathis T.
Brolucizumab for Choroidal Neovascular Membrane with Pigment Epithelial Tear and Subretinal Fluid. Journal of Clinical Medicine. 2021; 10(11):2425.
https://doi.org/10.3390/jcm10112425
Chicago/Turabian Style
Bilgic, Alper, Laurent Kodjikian, Shail Vasavada, Shyamal Jha, Samaresh Srivastava, Aditya Sudhalkar, and Thibaud Mathis.
2021. "Brolucizumab for Choroidal Neovascular Membrane with Pigment Epithelial Tear and Subretinal Fluid" Journal of Clinical Medicine 10, no. 11: 2425.
https://doi.org/10.3390/jcm10112425
APA Style
Bilgic, A., Kodjikian, L., Vasavada, S., Jha, S., Srivastava, S., Sudhalkar, A., & Mathis, T.
(2021). Brolucizumab for Choroidal Neovascular Membrane with Pigment Epithelial Tear and Subretinal Fluid. Journal of Clinical Medicine, 10(11), 2425.
https://doi.org/10.3390/jcm10112425